Daxor Cash on Hand 2010-2011 | DXR

Daxor cash on hand from 2010 to 2011. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Daxor Annual Cash on Hand
(Millions of US $)
2011 $56
2010 $54
2009 $54
Daxor Quarterly Cash on Hand
(Millions of US $)
2011-12-31 $56
2011-09-30 $52
2011-06-30 $54
2011-03-31 $53
2010-12-31 $54
2010-09-30 $58
2010-06-30 $49
2010-03-31 $76
2009-12-31 $54
2009-09-30 $70
2009-06-30 $70
2009-03-31 $58
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.039B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.351B 19.07
Encompass Health (EHC) United States $12.186B 25.83
DaVita (DVA) United States $10.288B 14.47
Chemed (CHE) United States $8.410B 26.43
Elanco Animal Health (ELAN) United States $6.675B 14.30
Option Care Health (OPCH) United States $5.351B 23.85
RadNet (RDNT) United States $4.313B 273.76
Amedisys (AMED) United States $3.087B 20.77
LifeStance Health (LFST) United States $2.310B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.390B 34.43
U.S Physical Therapy (USPH) United States $1.139B 29.41
Aveanna Healthcare Holdings (AVAH) United States $1.040B 59.22
Pennant (PNTG) United States $0.990B 36.34
Atai Life Sciences (ATAI) Germany $0.463B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.044B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00